Differences among dipyridamole, carbochromen and lidoflazine in responses of the coronary and the renal arteries.
D000081:Acetamides / Q000494:pharmacology; D000241:Adenosine / Q000494:pharmacology; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000503:physiopathology; D001794:Blood Pressure / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects; D003331:Coronary Vessels / Q000187:drug effects*; D003374:Coumarins / Q000008:administration & dosage / Q000494:pharmacology*; D004176:Dipyridamole / Q000008:administration & dosage / Q000494:pharmacology*; D004285:Dogs; D004357:Drug Synergism; D005260:Female; D006016:Glycolates / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D010879:Piperazines / Q000008:administration & dosage / Q000494:pharmacology*; D012039:Regional Blood Flow / Q000187:drug effects; D012077:Renal Artery / Q000187:drug effects*; D014665:Vasodilator Agents / Q000008:administration & dosage; D014992:Xylenes / Q000494:pharmacology
D000081:Acetamides; D003374:Coumarins; D006016:Glycolates; D010879:Piperazines; D014665:Vasodilator Agents; D014992:Xylenes; D004176:Dipyridamole; D000241:Adenosine; D009638:Norepinephrine